GR890100634A - Παραγωγα ιμιδαζολης. - Google Patents

Παραγωγα ιμιδαζολης.

Info

Publication number
GR890100634A
GR890100634A GR890100634A GR890100634A GR890100634A GR 890100634 A GR890100634 A GR 890100634A GR 890100634 A GR890100634 A GR 890100634A GR 890100634 A GR890100634 A GR 890100634A GR 890100634 A GR890100634 A GR 890100634A
Authority
GR
Greece
Prior art keywords
imidazole derivatives
imidazole
bile
reductase
inhibitors
Prior art date
Application number
GR890100634A
Other languages
English (en)
Inventor
Chuen Chan
Barry Olive Ross
Nigel Stephen Watson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823191A external-priority patent/GB8823191D0/en
Priority claimed from GB888823192A external-priority patent/GB8823192D0/en
Priority claimed from GB898902847A external-priority patent/GB8902847D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GR890100634A publication Critical patent/GR890100634A/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ωρισμένα νέα παράγωγα ιμιδαζόλης Ν-υποκατεστημένα δια μιας βινυλομάδος η οποία φέρει η ιδία ένα παράγωγον μεβαλονικού οξέος ή την αντίστοιχην λακτόνην είναι παρεμποδισταί της ρεδουκτάσης (χημικός τύπος) και είναι χρήσιμα δια την ελλάτωσι των περιεκτικοτήτων χοληστερίνης εις το πλάσμα του αίματος. ω
GR890100634A 1988-10-03 1989-10-03 Παραγωγα ιμιδαζολης. GR890100634A (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888823191A GB8823191D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB888823192A GB8823192D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB898902847A GB8902847D0 (en) 1989-02-09 1989-02-09 Chemical compounds

Publications (1)

Publication Number Publication Date
GR890100634A true GR890100634A (el) 1990-11-29

Family

ID=27264106

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100634A GR890100634A (el) 1988-10-03 1989-10-03 Παραγωγα ιμιδαζολης.

Country Status (19)

Country Link
US (2) US5013749A (el)
JP (1) JPH02188571A (el)
KR (1) KR900006297A (el)
AU (1) AU628862B2 (el)
BE (1) BE1003007A3 (el)
CH (1) CH680442A5 (el)
DE (1) DE3932887A1 (el)
DK (1) DK483689A (el)
ES (1) ES2019163A6 (el)
FI (1) FI894648A7 (el)
FR (1) FR2637183A1 (el)
GB (1) GB2223224B (el)
GR (1) GR890100634A (el)
IT (1) IT1237470B (el)
LU (1) LU87600A1 (el)
NL (1) NL8902441A (el)
NO (1) NO893909L (el)
PT (1) PT91878B (el)
SE (1) SE8903226L (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913725A1 (de) * 1989-04-26 1990-10-31 Basf Ag 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren
US5112819A (en) * 1989-10-10 1992-05-12 Glaxo Group Limited Imidazole derivatives, pharmaceutical compositions and use
JPWO2002030425A1 (ja) * 2000-10-12 2004-02-19 日産化学工業株式会社 糖尿病合併症予防・治療剤
EP1389107A4 (en) * 2001-04-27 2005-10-12 Bristol Myers Squibb Co BISARYLIMIDAZOLYL-FATTY ACID AMIDE-HYDROLASE INHIBITORS
BRPI0509926A (pt) * 2004-04-16 2007-09-18 Warner Lambert Co imidazóis
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
EP1755607A2 (en) * 2004-04-29 2007-02-28 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7199126B2 (en) * 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
JPWO2012046772A1 (ja) 2010-10-06 2014-02-24 国立大学法人 東京大学 リンパ浮腫予防治療剤

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007054A1 (en) * 1985-05-22 1986-12-04 Sandoz Ag Imidazole analogs of mevalonolactone and derivatives thereof
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
EP0221025A1 (en) * 1985-10-25 1987-05-06 Sandoz Ag Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals
EP0244364A2 (en) * 1986-04-30 1987-11-04 Sandoz Ag Preparation of olefinic compounds
EP0324347A2 (de) * 1988-01-09 1989-07-19 Hoechst Aktiengesellschaft Neue 3,5-Dihydroxycarbonsäuren und deren Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und Zwischenprodukte
EP0334014A2 (de) * 1988-02-25 1989-09-27 Bayer Ag Substituierte Imidazolinone und Imidazolinthione

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
WO1986007054A1 (en) * 1985-05-22 1986-12-04 Sandoz Ag Imidazole analogs of mevalonolactone and derivatives thereof
EP0221025A1 (en) * 1985-10-25 1987-05-06 Sandoz Ag Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals
EP0244364A2 (en) * 1986-04-30 1987-11-04 Sandoz Ag Preparation of olefinic compounds
EP0324347A2 (de) * 1988-01-09 1989-07-19 Hoechst Aktiengesellschaft Neue 3,5-Dihydroxycarbonsäuren und deren Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und Zwischenprodukte
EP0334014A2 (de) * 1988-02-25 1989-09-27 Bayer Ag Substituierte Imidazolinone und Imidazolinthione

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
US5120848A (en) 1992-06-09
LU87600A1 (fr) 1990-05-15
BE1003007A3 (fr) 1991-10-22
NO893909L (no) 1990-04-04
IT8948424A0 (it) 1989-10-02
NL8902441A (nl) 1990-05-01
FI894648L (fi) 1990-04-04
IT8948424A1 (it) 1991-04-02
FI894648A7 (fi) 1990-04-04
US5013749A (en) 1991-05-07
KR900006297A (ko) 1990-05-07
IT1237470B (it) 1993-06-07
FR2637183A1 (fr) 1990-04-06
FI894648A0 (fi) 1989-10-02
GB2223224B (en) 1992-01-08
DK483689D0 (da) 1989-10-02
NO893909D0 (no) 1989-10-02
DK483689A (da) 1990-04-04
GB8922212D0 (en) 1989-11-15
SE8903226D0 (sv) 1989-10-02
JPH02188571A (ja) 1990-07-24
AU4243189A (en) 1990-04-05
SE8903226L (sv) 1990-04-04
AU628862B2 (en) 1992-09-24
ES2019163A6 (es) 1991-06-01
DE3932887A1 (de) 1990-04-05
CH680442A5 (el) 1992-08-31
PT91878A (pt) 1990-04-30
GB2223224A (en) 1990-04-04
PT91878B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
ATE171068T1 (de) Chinoloncarbonsäurederivate, ihre herstellung und ihre verwendung als zelladhäsion inhibitoren
NO941680L (no) Monomere gallesyrederivater, fremgangsmåte for fremstilling av dem og deres anvendelse som legemiddel
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
NO941677L (no) Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel
FI96204C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
NO883073D0 (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter.
NL990030I1 (nl) Derivaten en analogen van 2-deoxy-2,3-didehydro-N-acetylneuraminezuur en het gebruik ervan als antivirale middelen.
NO881857L (no) Steroide 5-alfa-reduktase-inhibitorer.
MY117764A (en) Xanthine derivatives with end-aminated alkynol side chains.
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
AU4540789A (en) Imide derivatives, and their production and use
DE59303195D1 (de) Substituierte 4-Phenyl-pyridone und 4-Phenyl-2-alkoxypyridine als HMG-CoA-Reductase-Inhitoren
SE7906638L (sv) Peptidderivat
CY1107599T1 (el) Παραγωγα του οκταϋδρο-6, 10-διοξο-6h-πυριδαζινο [1,2-α] [1,2] διαζεπινη-1-καρβοξυλικου οξεος, η διαδικασια παρασκευης τους και η εφαρμογη τους στην παρασκευη θepαπευτικα ενepγων ενωσεων
ES2100396T3 (es) Derivados de 17-(3-furil)- y 17-(4-piridazinil)-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que los contienen.
ATE220660T1 (de) Cytostatische hydroxamsäurederivate
NO951136D0 (no) Syntese av N-acetyl neuraminsyre-derivater
SE8505487L (sv) Flavolignan derivat
AU4118193A (en) Tetronic, thiotetronic and tetramic acid derivatives as phospholipase A2 inhibitors
NO892454L (no) Fremgangsmaate for aa oeke molekylvekten av hydrocarboner og/eller hydrocarbonderivater.
ATE8137T1 (de) Antiallergische imidodisulfamide, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DK104388A (da) Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ATE19512T1 (de) 4-diphenylmethyl-1-((oxoalkyl)imino)methylpiperidine, und ihre derivate.